Enzymatics has launched version 3 of its Archer Analysis Pipeline. It's the latest incarnation of the company's next-generation sequence analysis platform for detecting and characterizing cancer-causing gene fusions and mutations from clinical samples. The solution lets users call known or novel genomic alterations. It includes robust quality control systems, clear, detailed analytics, and interactive visualizations using JBrowse, among other features.
DNAStar has launched Lasergene 12.1, which integrates cloud capability with desktop software to allow scientists to run multiple sequence assemblies on the cloud simultaneously. The solution also includes DNAStar Data Drive, which enables fast, secure data transfer between desktop computers and the cloud. It also includes protein function and binding site prediction tools and more.